JP2022500461A - 眼表面の損傷および乾燥の症状の治療のための眼科用組成物 - Google Patents

眼表面の損傷および乾燥の症状の治療のための眼科用組成物 Download PDF

Info

Publication number
JP2022500461A
JP2022500461A JP2021514550A JP2021514550A JP2022500461A JP 2022500461 A JP2022500461 A JP 2022500461A JP 2021514550 A JP2021514550 A JP 2021514550A JP 2021514550 A JP2021514550 A JP 2021514550A JP 2022500461 A JP2022500461 A JP 2022500461A
Authority
JP
Japan
Prior art keywords
composition
dryness
patient
eye
ocular surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021514550A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020058504A5 (https=
JP2022500461A5 (https=
Inventor
マルクス バイアー，
ダニエラ ヴィレン，
ソンヤ クレッサー，
トーマス シュレーター，
Original Assignee
ノバリック ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバリック ゲーエムベーハー filed Critical ノバリック ゲーエムベーハー
Publication of JP2022500461A publication Critical patent/JP2022500461A/ja
Publication of JPWO2020058504A5 publication Critical patent/JPWO2020058504A5/ja
Publication of JP2022500461A5 publication Critical patent/JP2022500461A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2021514550A 2018-09-22 2019-09-20 眼表面の損傷および乾燥の症状の治療のための眼科用組成物 Pending JP2022500461A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP18196126 2018-09-22
EP18196126.9 2018-09-22
EP18198440 2018-10-03
EP18198440.2 2018-10-03
EP18202041.2 2018-10-23
EP18202041 2018-10-23
PCT/EP2019/075406 WO2020058504A1 (en) 2018-09-22 2019-09-20 Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness

Publications (3)

Publication Number Publication Date
JP2022500461A true JP2022500461A (ja) 2022-01-04
JPWO2020058504A5 JPWO2020058504A5 (https=) 2022-09-27
JP2022500461A5 JP2022500461A5 (https=) 2022-09-27

Family

ID=68240699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021514550A Pending JP2022500461A (ja) 2018-09-22 2019-09-20 眼表面の損傷および乾燥の症状の治療のための眼科用組成物

Country Status (11)

Country Link
US (2) US20210346313A1 (https=)
EP (1) EP3852734A1 (https=)
JP (1) JP2022500461A (https=)
KR (1) KR20210080388A (https=)
CN (1) CN112739335A (https=)
AU (2) AU2019342426A1 (https=)
CA (1) CA3111873A1 (https=)
IL (1) IL281516A (https=)
PH (1) PH12021550621A1 (https=)
SG (1) SG11202102818YA (https=)
WO (1) WO2020058504A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348777B (zh) 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
USRE50060E1 (en) 2016-06-23 2024-07-30 Novaliq Gmbh Topical administration method
ES2969758T3 (es) 2016-09-22 2024-05-22 Novaliq Gmbh Composiciones farmacéuticas para usar en la terapia de la blefaritis
US10813976B2 (en) 2016-09-23 2020-10-27 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
PT3399962T (pt) 2016-12-23 2020-09-03 Novaliq Gmbh Composição oftálmica para o tratamento da doença do olho seco
CA3058097C (en) 2017-04-21 2024-01-02 Novaliq Gmbh Iodine compositions
KR20200059272A (ko) 2017-09-27 2020-05-28 노바리크 게엠베하 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
EP3758676A1 (en) 2018-03-02 2021-01-06 Novaliq GmbH Pharmaceutical compositions comprising nebivolol
KR102882058B1 (ko) 2018-03-28 2025-11-07 노바리크 게엠베하 티몰롤을 포함하는 약제학적 조성물
JP2021522219A (ja) 2018-04-27 2021-08-30 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
CN113710228A (zh) 2019-02-13 2021-11-26 诺瓦利克有限责任公司 用于治疗眼部新生血管形成的组合物和方法
US12419933B2 (en) 2019-09-06 2025-09-23 Novaliq Gmbh Ophthalmic composition for the treatment of uveitis

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005523313A (ja) * 2002-04-16 2005-08-04 コッラジェネックス ファーマシューチカルス インコーポレイテッド 目の酒さ及び酒さ性ざ瘡の同時治療方法
JP2013513586A (ja) * 2009-12-14 2013-04-22 ノバリック ゲーエムベーハー ドライアイ症候群の治療のための医薬組成物
JP2015527386A (ja) * 2012-09-12 2015-09-17 ノバリック ゲーエムベーハー 半フッ素化アルカン組成物
JP2016065089A (ja) * 2007-08-16 2016-04-28 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド 眼および付属器組織の炎症を処置するための治療組成物
JPWO2016056644A1 (ja) * 2014-10-09 2017-04-27 株式会社メディプロデュース まつ毛用洗浄剤
WO2018054932A1 (en) * 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19938668B4 (de) 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
CN113679697A (zh) 2012-09-12 2021-11-23 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
CN108348777B (zh) * 2015-09-30 2020-04-28 诺瓦利克有限责任公司 半氟化化合物和其组合物
CN111182893A (zh) * 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005523313A (ja) * 2002-04-16 2005-08-04 コッラジェネックス ファーマシューチカルス インコーポレイテッド 目の酒さ及び酒さ性ざ瘡の同時治療方法
JP2016065089A (ja) * 2007-08-16 2016-04-28 ザ スキーペンズ アイ リサーチ インスティチュート インコーポレイテッド 眼および付属器組織の炎症を処置するための治療組成物
JP2013513586A (ja) * 2009-12-14 2013-04-22 ノバリック ゲーエムベーハー ドライアイ症候群の治療のための医薬組成物
JP2015527386A (ja) * 2012-09-12 2015-09-17 ノバリック ゲーエムベーハー 半フッ素化アルカン組成物
JPWO2016056644A1 (ja) * 2014-10-09 2017-04-27 株式会社メディプロデュース まつ毛用洗浄剤
WO2018054932A1 (en) * 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
CLIN. OPHTHALMOL., vol. 2014:8, JPN6024015568, 2014, pages 581 - 590, ISSN: 0005628822 *
CLIN. SCI., vol. 33, no. 5, JPN6024052965, 2014, pages 448 - 452, ISSN: 0005501025 *
CORNEA, vol. 31, no. 4, JPN6023035629, 2012, pages 396 - 404, ISSN: 0005313916 *
J. OCUL. PHARMACOL. THER., vol. 33, no. 9, JPN6023035630, 2017, pages 678 - 685, ISSN: 0005628824 *
J.OCUL.PHARMACOL.THER., vol. 31, no. 8, JPN6023035631, 2015, pages 498 - 503, ISSN: 0005313915 *
KOMPASS OPHTHALMOL., vol. 2, no. 2, JPN6023035632, 2016, ISSN: 0005628825 *
OCUL. SURF., vol. 5, no. 2, JPN6024052964, 2007, pages 153 - 162, ISSN: 0005501026 *
あたらしい眼科, vol. 27(5), JPN6024015567, 2010, pages 627 - 631, ISSN: 0005628823 *

Also Published As

Publication number Publication date
US20250295607A1 (en) 2025-09-25
PH12021550621A1 (en) 2022-02-14
AU2025204313A1 (en) 2025-06-26
AU2019342426A1 (en) 2021-05-20
CA3111873A1 (en) 2020-03-26
EP3852734A1 (en) 2021-07-28
KR20210080388A (ko) 2021-06-30
SG11202102818YA (en) 2021-04-29
CN112739335A (zh) 2021-04-30
US20210346313A1 (en) 2021-11-11
IL281516A (en) 2021-04-29
WO2020058504A1 (en) 2020-03-26

Similar Documents

Publication Publication Date Title
US20250295607A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
US12569452B2 (en) Ophthalmic compositions comprising F6H8
US12059449B2 (en) Ophthalmic composition for treatment of dry eye disease
Park et al. Clinical effects and safety of 3% diquafosol ophthalmic solution for patients with dry eye after cataract surgery: a randomized controlled trial
HK1201042A1 (en) Compositions for the treatment of dry eye
KR20210127197A (ko) 4-(7-히드록시-2-이소프로필-4-옥소-4h-퀴나졸린-3-일)-벤조니트릴의 제형
JP2007530573A (ja) ドライアイの治療にロテプレドノールエタボネートを使用すること
JP2025004186A (ja) 眼表面疼痛を治療する方法
RU2806212C2 (ru) Офтальмологические композиции для лечения повреждения поверхности глаза и симптомов сухости глаз
CA3076567C (en) Ophthalmic compositions comprising f6h8
RU2828769C2 (ru) Офтальмологические композиции для лечения синдрома сухого глаза
HK40028751A (en) Ophthalmic compositions comprising f6h8
HK40114301A (en) Ophthalmic composition for treatment of dry eye disease
HK40058504B (en) Ophthalmic composition for treatment of dry eye disease
HK40058504A (en) Ophthalmic composition for treatment of dry eye disease
Lemp The Tear-Deficient Patient

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220915

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220915

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230823

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230901

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240430

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240717

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241030

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250509